Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarilumab TARGET study in RA
NCT01709578Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2012
- Primary completion
- Mar 2015
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 30
01
Overview
A Phase 3 trial of sarilumab in rheumatoid arthritis (RA), sponsored by Sanofi. Started Oct 2012; status: completed.
02
Drugs
sarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01709578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01709578.